Click for best price
Postpemic Era Cord Blood Stem Cells Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
(Post-pandemic Era)-Global Cord Blood Stem Cells Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Cord Blood Stem Cells industry at home and abroad, estimate the overall market scale of the Cord Blood Stem Cells industry and the market share of major countries, Cord Blood Stem Cells industry, and study and judge the downstream market demand of Cord Blood Stem Cells through systematic research, Analyze the competition pattern of Cord Blood Stem Cells, so as to help solve the pain points of various stakeholders in Cord Blood Stem Cells industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Cord Blood Stem Cells Market by Research Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Cord Blood Stem Cells Market?
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics Inc.
Athersys Inc.
Geron Corporation
Neostem Inc.
CBR Systems, Inc.
Cordlife
Cryo-Cell
Cryo-Save AG (A Group of Esperite)
Lifecell
Stemcyte
Viacord
Smart Cells International Ltd.
Cryoviva India
Cordvida
China Cord Blood Corporation
Major Type of Cord Blood Stem Cells Covered in Research report:
Allogeneic Stem Cell
Autologous Stem Cell
Application Segments Covered in Research Market
Autoimmune Diseases
Immunodeficiencies
Malignancies,Caners
Solid Tumors
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Cord Blood Stem Cells Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
99 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Cord Blood Stem Cells Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Cord Blood Stem Cells Market by Value
2.2.1 Global Cord Blood Stem Cells Revenue by Type
2.2.2 Global Cord Blood Stem Cells Market by Value
2.3 Global Cord Blood Stem Cells Market by Sales
2.3.1 Global Cord Blood Stem Cells Sales by Type
2.3.2 Global Cord Blood Stem Cells Market by Sales
3. The Major Driver of Cord Blood Stem Cells Industry
3.1 Historical & Forecast Global Cord Blood Stem Cells Sales and Revenue (2018-2028)
3.2 Largest Application for Cord Blood Stem Cells (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Cord Blood Stem Cells Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Cord Blood Stem Cells Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Cord Blood Stem Cells Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Cord Blood Stem Cells Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Cord Blood Stem Cells Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Cord Blood Stem Cells Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Cord Blood Stem Cells Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Cord Blood Stem Cells Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Cord Blood Stem Cells Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Cord Blood Stem Cells Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Cord Blood Stem Cells Average Price Trend
13.1 Market Price for Each Type of Cord Blood Stem Cells in US (2018-2022)
13.2 Market Price for Each Type of Cord Blood Stem Cells in Europe (2018-2022)
13.3 Market Price for Each Type of Cord Blood Stem Cells in China (2018-2022)
13.4 Market Price for Each Type of Cord Blood Stem Cells in Japan (2018-2022)
13.5 Market Price for Each Type of Cord Blood Stem Cells in India (2018-2022)
13.6 Market Price for Each Type of Cord Blood Stem Cells in Korea (2018-2022)
13.7 Market Price for Each Type of Cord Blood Stem Cells in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Cord Blood Stem Cells in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Cord Blood Stem Cells Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Cord Blood Stem Cells
15. Cord Blood Stem Cells Competitive Landscape
15.1 Advanced Cell Technology
15.1.1 Advanced Cell Technology Company Profiles
15.1.2 Advanced Cell Technology Product Introduction
15.1.3 Advanced Cell Technology Cord Blood Stem Cells Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 California Stem Cell
15.2.1 California Stem Cell Company Profiles
15.2.2 California Stem Cell Product Introduction
15.2.3 California Stem Cell Cord Blood Stem Cells Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Cytori Therapeutics
15.3.1 Cytori Therapeutics Company Profiles
15.3.2 Cytori Therapeutics Product Introduction
15.3.3 Cytori Therapeutics Cord Blood Stem Cells Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Mesoblast Limited
15.4.1 Mesoblast Limited Company Profiles
15.4.2 Mesoblast Limited Product Introduction
15.4.3 Mesoblast Limited Cord Blood Stem Cells Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Opexa Therapeutics Inc.
15.5.1 Opexa Therapeutics Inc. Company Profiles
15.5.2 Opexa Therapeutics Inc. Product Introduction
15.5.3 Opexa Therapeutics Inc. Cord Blood Stem Cells Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Athersys Inc.
15.6.1 Athersys Inc. Company Profiles
15.6.2 Athersys Inc. Product Introduction
15.6.3 Athersys Inc. Cord Blood Stem Cells Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Geron Corporation
15.7.1 Geron Corporation Company Profiles
15.7.2 Geron Corporation Product Introduction
15.7.3 Geron Corporation Cord Blood Stem Cells Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Neostem Inc.
15.8.1 Neostem Inc. Company Profiles
15.8.2 Neostem Inc. Product Introduction
15.8.3 Neostem Inc. Cord Blood Stem Cells Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 CBR Systems, Inc.
15.9.1 CBR Systems, Inc. Company Profiles
15.9.2 CBR Systems, Inc. Product Introduction
15.9.3 CBR Systems, Inc. Cord Blood Stem Cells Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Cordlife
15.10.1 Cordlife Company Profiles
15.10.2 Cordlife Product Introduction
15.10.3 Cordlife Cord Blood Stem Cells Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 Cryo-Cell
15.12 Cryo-Save AG (A Group of Esperite)
15.13 Lifecell
15.14 Stemcyte
15.15 Viacord
15.16 Smart Cells International Ltd.
15.17 Cryoviva India
15.18 Cordvida
15.19 China Cord Blood Corporation
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Cord Blood Stem Cells Industry (Volume)
Figure 2. Cord Blood Stem Cells Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Cord Blood Stem Cells Revenue in 2022
Figure 5. US Cord Blood Stem Cells Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Cord Blood Stem Cells Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Cord Blood Stem Cells Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Cord Blood Stem Cells Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Cord Blood Stem Cells Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Cord Blood Stem Cells Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Cord Blood Stem Cells Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Cord Blood Stem Cells Revenue, by Type (Million USD) (2018-2028)
Table 4. Cord Blood Stem Cells Sales, by Type (K Unit) (2018-2028)
Table 5. Cord Blood Stem Cells Sales (K Unit) by Application (2018-2028)
Table 6. Cord Blood Stem Cells Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Cord Blood Stem Cells Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Cord Blood Stem Cells Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Cord Blood Stem Cells Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Cord Blood Stem Cells Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Cord Blood Stem Cells Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Cord Blood Stem Cells Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Cord Blood Stem Cells Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Cord Blood Stem Cells Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Cord Blood Stem Cells in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Cord Blood Stem Cells in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Cord Blood Stem Cells in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Cord Blood Stem Cells in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Cord Blood Stem Cells in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Cord Blood Stem Cells in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Cord Blood Stem Cells in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Advanced Cell Technology Profiles
Table 61. Advanced Cell Technology Cord Blood Stem Cells Product Introduction
Table 62. Advanced Cell Technology Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Advanced Cell Technology Strategic initiatives
Table 64. California Stem Cell Profiles
Table 65. California Stem Cell Cord Blood Stem Cells Product Introduction
Table 66. California Stem Cell Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. California Stem Cell Strategic initiatives
Table 68. Cytori Therapeutics Profiles
Table 69. Cytori Therapeutics Cord Blood Stem Cells Product Introduction
Table 70. Cytori Therapeutics Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Cytori Therapeutics Strategic initiatives
Table 72. Mesoblast Limited Profiles
Table 73. Mesoblast Limited Cord Blood Stem Cells Product Introduction
Table 74. Mesoblast Limited Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Mesoblast Limited Strategic initiatives
Table 76. Opexa Therapeutics Inc. Profiles
Table 77. Opexa Therapeutics Inc. Cord Blood Stem Cells Product Introduction
Table 78. Opexa Therapeutics Inc. Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Opexa Therapeutics Inc. Strategic initiatives
Table 80. Athersys Inc. Profiles
Table 81. Athersys Inc. Cord Blood Stem Cells Product Introduction
Table 82. Athersys Inc. Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Athersys Inc. Strategic initiatives
Table 84. Geron Corporation Profiles
Table 85. Geron Corporation Cord Blood Stem Cells Product Introduction
Table 86. Geron Corporation Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Geron Corporation Strategic initiatives
Table 88. Neostem Inc. Profiles
Table 89. Neostem Inc. Cord Blood Stem Cells Product Introduction
Table 90. Neostem Inc. Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Neostem Inc. Strategic initiatives
Table 92. CBR Systems, Inc. Profiles
Table 93. CBR Systems, Inc. Cord Blood Stem Cells Product Introduction
Table 94. CBR Systems, Inc. Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. CBR Systems, Inc. Strategic initiatives
Table 97. Cordlife Profiles
Table 98. Cordlife Cord Blood Stem Cells Product Introduction
Table 99. Cordlife Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Cordlife Strategic initiatives
Table 101. Cryo-Cell Profiles
Table 102. Cryo-Cell Cord Blood Stem Cells Product Introduction
Table 103. Cryo-Cell Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Cryo-Cell Strategic initiatives
Table 105. Cryo-Save AG (A Group of Esperite) Profiles
Table 106. Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Product Introduction
Table 107. Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. Cryo-Save AG (A Group of Esperite) Strategic initiatives
Table 109. Lifecell Profiles
Table 110. Lifecell Cord Blood Stem Cells Product Introduction
Table 111. Lifecell Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 112. Lifecell Strategic initiatives
Table 113. Stemcyte Profiles
Table 114. Stemcyte Cord Blood Stem Cells Product Introduction
Table 115. Stemcyte Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 116. Stemcyte Strategic initiatives
Table 117. Viacord Profiles
Table 118. Viacord Cord Blood Stem Cells Product Introduction
Table 119. Viacord Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 120. Viacord Strategic initiatives
Table 121. Smart Cells International Ltd. Profiles
Table 122. Smart Cells International Ltd. Cord Blood Stem Cells Product Introduction
Table 123. Smart Cells International Ltd. Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 124. Smart Cells International Ltd. Strategic initiatives
Table 125. Cryoviva India Profiles
Table 126. Cryoviva India Cord Blood Stem Cells Product Introduction
Table 127. Cryoviva India Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 128. Cryoviva India Strategic initiatives
Table 129. Cordvida Profiles
Table 130. Cordvida Cord Blood Stem Cells Product Introduction
Table 131. Cordvida Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 132. Cordvida Strategic initiatives
Table 133. China Cord Blood Corporation Profiles
Table 134. China Cord Blood Corporation Cord Blood Stem Cells Product Introduction
Table 135. China Cord Blood Corporation Cord Blood Stem Cells Sales (Unit), Revenue (Million USD) (2018-2022)
Table 136. China Cord Blood Corporation Strategic initiatives
